Language : English
Published : 2017-11-30
Pages : 624
Social Psychology 9th Global Edition
For courses in Social PsychologyMake research relevant through a storytelling approach.Social Psychology introduces the key concepts of the field through an acclaimed storytelling approach that makes research relevant to students. Drawing upon their extensive experience as researchers and teachers, Elliot Aronson, Tim Wilson, Robin Akert, and new co-author Sam Sommers present the classic studies that have driven the discipline alongside the cutting-edge research that is the future of social psychology. MyLabTM Psychology not included. Students, if MyLab is a recommended/mandatory component of the course, please ask your instructor for the correct ISBN and course ID. MyLab should only be purchased when required by an instructor. Instructors, contact your Pearson rep for more information. MyLab is an online homework, tutorial, and assessment product designed to personalize learning and improve results. With a wide range of interactive, engaging, and assignable activities, students are encouraged to actively learn and retain tough course concepts.
New and emerging directions in pharmaceutical research to better treat schizophrenia
Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.
Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential new drugs and therapeutics. It begins with a discussion of prevalence and etiology. Then, it describes therapies such as dopamine agonists and phosphodiesterase (PDE) inhibitors as well as growing research aimed at addressing untreated symptoms. Next, the authors discuss receptor modulators, inhibitors, and targeting strategies for drug discovery. Both the neurobiological and chemical aspects of all major pharmacological targets are examined.
With contributions from an international team of pioneering pharmaceutical researchers, this book compiles the current knowledge in the field, setting the stage for new breakthroughs in the treatment of schizophrenia. Targets and Emerging Therapies for Schizophrenia:
- Provides a comprehensive resource for neuro-drug discovery and the development of molecular targets for schizophrenia treatment
- Draws from chemistry, biology, and pharmacology for more effective drug targeting and discovery
- Explores a wide range of receptors and molecular targets, including dopamine, PDEs, and neuropeptides
With Targets and Emerging Therapies for Schizophrenia as their guide, drug discovery and development scientists have the information they need to advance their own research so that new, more effective treatments for schizophrenia will soon be a reality.
Without medical jargon, Barbara Schildkrout lucidly explains how patients with each medical condition may end up seeking help from a mental health professional.
The conditions explored in this book include:
- Alzheimer’s disease
- Brain tumors
- Carbon monoxide poisoning
- Diseases of the thyroid
- Endocrine disorders
- Hepatic encephalopathy
- Hyperventilation syndrome
- Limbic encephalitis
- Lyme disease
- Thiamine deficiency
- Traumatic brain injury
The book also describes a proven process for working with patients during and after the referral process, and integrating medical findings into ongoing therapeutic work. All mental health professionals need access to this information, and Masquerading Symptoms puts it all in a single, easily navigated reference.BARBARA SCHILDKROUT, MD,is an Assistant Clinical Professor of Psychiatry at Harvard Medical School. She has taught for many years at the Beth Israel Deaconess Medical Center. She has a Subspecialty Board Certification through the United Council for Neurological Subspecialties in behavioral neurology and neuropsychiatry and has maintained a private clinical practice in the Boston area for over 25 years.
About the Author
BARBARA SCHILDKROUT, MD, is an Assistant Clinical Professor of Psychiatry at Harvard Medical School. She has taught for many years at the Beth Israel Deaconess Medical Center. She has a Subspecialty Board Certification through the United Council for Neurological Subspecialties in behavioral neurology and neuropsychiatry and has maintained a private clinical practice in the Boston area for over twenty-five years.
Nelson Psychology: Second Edition, has been developed for the YouTube generation. The contemporary design and new features will automatically connect with your students and enhance their enjoyment of Psychology. Nelson Psychology will fully prepare them for success in their Units 3 & 4 exam.
Articulation and Phonological Disorders: Speech Sound Disorders in Children 7th International Edition
A classic in the field, Articulation and Phonological Disorders: Speech Sound Disorders in Children, 7e, presents the most up-to-date perspectives on the nature, assessment, and treatment of speech sound disorders. A must-have reference, this classic book delivers exceptional coverage of clinical literature and focuses on speech disorders of unknown causes. Offering a range of perspectives, it covers the normal aspects of speech sound articulation, normal speech sound acquisition, the classification of and factors related to the presence of phonological disorders, the assessment and remediation of speech sound disorders, and phonology as it relates to language and dialectal variations. This edition features twelve manageable chapters, including a new chapter on the classification of speech sound disorders, an expanded discussion of childhood apraxia of speech, additional coverage of evidence-based practices, and a look at both motor-based and linguistically-based treatment approaches.
About the Author
Dr. John Bernthal is professor emeritus of Special Education and Communication Sciences and Disorders at the University of Nebraska-Lincoln. He has been a speech-language pathologist for over forty years, including employment in the public schools, at several universities, and professor and department chair for over thirty years. He conducted research, taught and published in the area of speech sounds disorders. He is a past president of the American Speech Language Hearing Association, an ASHA Fellow, and recipient of Honors of the Association. Dr. Nicholas Bankson is a professor emeritus at James Madison University. He has had a forty year career as a speech-language pathologist, including employment in the public schools, serving as the state supervisor of school programs in Kansas, plus twenty-seven years as a department chair in Communication Sciences and Disorders at Boston University and James Madison University. His scholarly efforts have focused on speech sound disorders and the assessment of language disorders in children. He is an ASHA Fellow, and a recipient ASHA’s Honors of the Association award. Dr. Peter Flipsen Jr., is a professor of Speech-Language Pathology at Idaho State University. He has more than twenty years of experience in the field as a clinician, teacher, and researcher. He teaches courses in phonetics and speech sound disorders in children and has published more than twenty peer-reviewed journal articles in the field. His research has focused on the classification of speech sound disorders, measurement of intelligibility of speech, and speech and language development in children with cochlear implants.